<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02621619</url>
  </required_header>
  <id_info>
    <org_study_id>2015-5369</org_study_id>
    <secondary_id>7K23AG033100-07</secondary_id>
    <nct_id>NCT02621619</nct_id>
  </id_info>
  <brief_title>IV Acetaminophen as an Analgesic Adjunct</brief_title>
  <official_title>Randomized Clinical Trial of IV Acetaminophen as an Analgesic Adjunct to IV Hydromorphone in the Treatment of Acute Severe Pain in Elderly ED Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montefiore Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Montefiore Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the efficacy of IV acetaminophen as an analgesic adjunct to IV hydromorphone in
      the treatment of acute severe pain in the elderly ED patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized controlled trial to determine the efficacy of 1 gram IV acetaminophen as an
      analgesic adjunct to 0.5 mg IV hydromorphone in the treatment of acute severe pain in the
      elderly ED patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Between group difference in before-after numerical rating scale (NRS) pain scores</measure>
    <time_frame>60 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Between group difference in before-after numerical rating scale (NRS) pain scores</measure>
    <time_frame>5 min, 15 min, 30 min, and 45 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Between group difference in proportion who decline additional pain medication when asked</measure>
    <time_frame>60 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse effects</measure>
    <time_frame>5, 15, 30, 45, and 60 minutes</time_frame>
    <description>Between group difference in adverse effects</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">162</enrollment>
  <condition>Acute Pain</condition>
  <arm_group>
    <arm_group_label>IV acetaminophen + 0.5 mg IV hydromorphone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 gram IV acetaminophen in addition to 0.5 mg IV hydromorphone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo + 0.5 mg IV hydromorphone</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>100 ml normal saline placebo in addition to 0.5 mg IV hydromorphone</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IV acetaminophen + 0.5 mg IV hydromorphone</intervention_name>
    <description>1 gram (100 ml) IV acetaminophen in addition to 0.5 mg IV hydromorphone</description>
    <arm_group_label>IV acetaminophen + 0.5 mg IV hydromorphone</arm_group_label>
    <other_name>Ofirmev</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline + 0.5 mg IV hydromorphone</intervention_name>
    <description>100 cc normal saline placebo in addition to 0.5 mg IV hydromorphone</description>
    <arm_group_label>Placebo + 0.5 mg IV hydromorphone</arm_group_label>
    <other_name>Placebo</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.5 mg IV hydromorphone</intervention_name>
    <description>Both groups (intervention and placebo) will receive 0.5 mg IV hydromorphone</description>
    <arm_group_label>IV acetaminophen + 0.5 mg IV hydromorphone</arm_group_label>
    <arm_group_label>Placebo + 0.5 mg IV hydromorphone</arm_group_label>
    <other_name>Dilaudid</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acute (less than 1 week in duration) severe pain necessitating use of IV opioids in
             the judgement of the treating attending physician

        Exclusion Criteria:

          -  Use of other opioids or tramadol within past 24 hours: to avoid introducing assembly
             bias related to recent opioid use, since this may affect baseline levels of pain and
             need for analgesics.

          -  Prior adverse reaction to hydromorphone, morphine, or acetaminophen.

          -  Chronic pain syndrome: frequently recurrent or daily pain for at least 3 months
             results in modulation of pain perception which is thought to be due to down-regulation
             of pain receptors. Examples of chronic pain syndromes include sickle cell anemia,
             osteoarthritis, fibromyalgia, and peripheral neuropathies.

          -  Alcohol intoxication: the presence of alcohol intoxication as judged by the treating
             physician may alter pain perception.

          -  SBP &lt;100 mm Hg: Opioids can produce peripheral vasodilation that may result in
             orthostatic hypotension.

          -  HR &lt; 60/min: Opioids can cause bradycardia.

          -  Oxygen saturation &lt; 95% on room air: For this study, oxygen saturation must be 95% or
             above on room air in order to be enrolled.

          -  Use of MAO inhibitors in past 30 days: MAO inhibitors have been reported to intensify
             the effects of at least one opioid drug causing anxiety, confusion and significant
             respiratory depression or coma.

          -  Patients using transdermal pain patches
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Montefiore Medical Center Moses Division Emergency Department</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Chang, MD, MS</last_name>
      <phone>718-920-6626</phone>
      <email>achang3@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Andrew K Chang, MD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 21, 2015</study_first_submitted>
  <study_first_submitted_qc>December 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 3, 2015</study_first_posted>
  <last_update_submitted>March 27, 2018</last_update_submitted>
  <last_update_submitted_qc>March 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Montefiore Medical Center</investigator_affiliation>
    <investigator_full_name>Andrew Chang, MD</investigator_full_name>
    <investigator_title>Professor of Clinical Emergency Medicine</investigator_title>
  </responsible_party>
  <keyword>Older adults</keyword>
  <keyword>Elderly</keyword>
  <keyword>Acute pain</keyword>
  <keyword>IV acetaminophen</keyword>
  <keyword>IV hydromorphone</keyword>
  <keyword>Analgesia</keyword>
  <keyword>Adjunctive analgesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Analgesics</mesh_term>
    <mesh_term>Hydromorphone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

